These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17140171)

  • 1. Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia.
    Basse G; Ribes D; Kamar N; Esposito L; Rostaing L
    Clin Nephrol; 2006 Nov; 66(5):395-6. PubMed ID: 17140171
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report.
    Massari M; Catania A; Magnani G
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S134-5. PubMed ID: 17936216
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplantation; 2005 Dec; 80(11):1560-4. PubMed ID: 16371926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
    Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
    Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia.
    Meersseman W; Lagrou K; Sciot R; de Jonckheere J; Haberler C; Walochnik J; Peetermans WE; van Wijngaerden E
    Emerg Infect Dis; 2007 Mar; 13(3):469-71. PubMed ID: 17552103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.
    Mitsuhata N; Fujita R; Ito S; Mannami M; Keimei K
    Transplantation; 2005 Nov; 80(9):1355. PubMed ID: 16314808
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
    Cohen C; Mekinian A; Saidenberg-Kermanac'h N; Stirnemann J; Fenaux P; Gherardi R; Fain O
    Ann Rheum Dis; 2012 Apr; 71(4):628-9. PubMed ID: 22121135
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient.
    Kumar D; Gourishankar S; Mueller T; Cockfield S; Weinkauf J; Vethanayagam D; Humar A
    Transpl Infect Dis; 2009 Apr; 11(2):167-70. PubMed ID: 18803617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with rituximab in a patient with mononeuritis multiplex asocciated to hepatitis C infection with mixed cryoglobulinemia].
    Ivorra J; Muñoz S; Román-Ivorra J; Beltrán E
    Med Clin (Barc); 2009 Mar; 132(11):444-5. PubMed ID: 19268328
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.
    Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II.
    Moberg P; Charles JF; Respicio G; Venna SS; Rooney T
    Cutis; 2010 Sep; 86(3):133-5. PubMed ID: 21049729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
    Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
    Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal adenoviral hepatitis after rituximab therapy.
    Iyer A; Mathur R; Deepak BV; Sinard J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1557-60. PubMed ID: 17090202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in mixed cryoglobulinemia: increased experience and perspectives.
    De Vita S; Quartuccio L; Fabris M
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S122-8. PubMed ID: 17936213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
    Baerlecken NT; Schmidt RE
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical improvement induced by rituximab in two cases of type II mixed cryoglobulinaemia syndrome unresponsive to conventional treatments.
    Cabibbo S; Antolino A; Garozzo G; Manenti GO; Bonomo P
    Blood Transfus; 2010 Jul; 8(3):196-8. PubMed ID: 20671881
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure.
    Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D
    Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy.
    Chung BH; Yun JT; Ha SE; Kim JI; Moon IS; Choi BS; Park CW; Kim YS; Yang CW
    Transpl Infect Dis; 2013 Dec; 15(6):559-68. PubMed ID: 24011062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.